Skip to main content
Log in

Quality of care of rural rheumatoid arthritis patients in Austria

Die Versorgungsqualität von Patienten mit rheumatoider Arthritis im ländlichen Raum

  • original article
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

Summary

Objectives

To determine how fast rheumatoid arthritis (RA) was diagnosed in a group of patients in a rural area and whether medical care and patient satisfaction were adequate in a predominantly non-urban settlement.

Methods

When visiting their rheumatologist, patients with RA were asked to complete a questionnaire at home after the consultation and then return it to an independent opinion research centre, where the data were collected and analysed. The form comprised various areas, namely demography, aspects of the diagnosis, medical care, therapeutic measures and the illness in a personal context.

Results

Of 150 patients, 127 answered the questionnaire. A total of 63 % of the patients lived in settlements of less than 5,000 inhabitants, and a further 18 % in settlements of more than 5,000–50,000 inhabitants. The rheumatologist attended could be reached within 1 h for 90 % of the patients.

In slightly fewer than 30 % of the respondents, the diagnosis of RA was made within 3 months, and in 44%, within 6 months. In 75 %, the diagnosis was made by a rheumatologist. After experiencing the first symptoms, 80 % of the respondents contacted their general practitioner. A high degree of satisfaction appears to originate from the information supplied by the rheumatologist attended. Most patients believed they were involved in decision making regarding their therapy.

Conclusion

The majority of the respondents came from rural areas. RA was diagnosed within 6 months for almost half of the patients questioned. Most patients believed they were well informed and involved in therapeutic decision making.

Zusammenfassung

Ziel

Es soll festgestellt werden, wie schnell eine rheumatoide Arthritis (RA) bei Patienten in einer ländlichen Region diagnostiziert wird und ob die medizinische Versorgung und Patientenzufriedenheit in einer nicht-städtischen Umgebung entsprechend ist.

Methoden

Ein Fragebogen wurde an Patienten mit rheumatoider Arthritis im Rahmen einer Visite bei ihrem Rheumatologen ausgehändigt. Dieser wurde zu Hause ausgefüllt und an ein unabhängiges Meinungsforschungsinstitut retourniert, wo die Daten gesammelt und analysiert wurden. Das Formular umfasst die Bereiche Demographie, Aspekte der Diagnose, medizinische Versorgung und die Krankheit in einem persönlichen Kontext.

Ergebnisse

127 Patienten beantworteten den Fragebogen; 63 % der Befragten waren aus Orten unter 5000 Einwohner, weitere 18 % aus Orten mit 5000 bis 50.000 Einwohnern. Der behandelnde Rheumatologe war für 90 % der Erkrankten innerhalb einer Stunde erreichbar.

Nur bei knapp 30 % der Befragten wurde innerhalb von 3 Monaten die Diagnose einer RA gestellt, bei 44 % innerhalb von 6 Monaten. Bei 80 % war der erste Ansprechpartner nach Auftreten von Symptomen der Hausarzt. Bei 75 % der Befragten wurde die Diagnose schließlich durch einen Rheumatologen gestellt. Es besteht hohe Zufriedenheit mit der Information durch die behandelnden Rheumatologen. Die meisten Patienten werden in die Entscheidung hinsichtlich ihrer Therapieform einbezogen.

Fazit

Die Mehrheit der Befragten kam aus dem ländlichen Raum. Bei fast der Hälfte der Patienten wurde die Diagnose einer RA innerhalb von 6 Monaten gestellt. Die meisten Patienten fühlten sich gut informiert und in die therapeutische Entscheidungsfindung einbezogen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Basu N, Steven M. A comparison of rural and urban rheumatoid arthritis populations. Scott Med J. 2009;54(1):7–9.

    Article  CAS  PubMed  Google Scholar 

  2. Bejarano V, Quinn M, Conaghan PG, et al.; Yorkshire Early Arthritis Register Consortium. Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis. Arthritis Rheum. 2008;59:1467–74.

    Article  PubMed  Google Scholar 

  3. Buitinga L, Braakman-Jansen LM, van de Laar MA. Future expectations and worst-case future scenarios of patients with rheumatoid arthritis: a focus group study. Musculoskeletal Care. 2012;10(4):240–7.

    Article  PubMed  Google Scholar 

  4. Bykerk V, Emery P. Delay in receiving rheumatology care leads to long term harm. Arthritis Rheum. 2010;62:3519–21.

    Article  PubMed  Google Scholar 

  5. Carr A, Hewlett S, Hughes R, Mitchell H, Ryan S, Carr M, Kirwan J. Rheumatology outcomes: the patient's perspective. J Rheumatol. 2003;30:880–3.

    PubMed  Google Scholar 

  6. Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum. 2005;52:3381–90.

    Article  CAS  PubMed  Google Scholar 

  7. Gromnica-Ihle E. Rink M. Treat to target from the patient perspective. Z Rheumatol. 2011;70:678–84.

    Google Scholar 

  8. Hill J, Bird H, Johnson S. Effect of patient education on adherence to drug treatment for rheumatoid arthritis: a randomised controlled trial. Ann Rheum Dis. 2001;60:869–75.

    CAS  PubMed Central  PubMed  Google Scholar 

  9. Jaccobi C, Boshuizen H, Rupp I, et al. Quality of rheumatoid arthritis care: the patient's perspective. Int J Qual Health Care. 2004;16:73–81.

    Article  Google Scholar 

  10. Kalden JR, Müller-Ladner U, Schmiedt RE. Strategies for improved healthcare of people with the endemic disease rheumatism exemplified by rheumatoid arthritis. Z Rheumatol. 2011;70:641–50.

    Article  CAS  PubMed  Google Scholar 

  11. Kjeken I, Dagfinrud H, Mowinckel P, et al. Rheumatology care: involvement in medical decisions, received information, satisfaction with care, and unmet health care needs in patients with rheumatoid arthritis and ankylosing spondylitis. Arthritis Rheum. 2006;55:394–401.

    Article  PubMed  Google Scholar 

  12. Krüger K, Karberg K. Treat-to-target from the perspective of office-based rheumatology. Z Rheumatol. 2011;70:664–9.

    Article  PubMed  Google Scholar 

  13. Machold KP, Stamm TA, Nell VPK, et al. Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiograph progression over the first years of disease. Rheumatology (Oxford). 2007;46:342–9.

    Article  CAS  Google Scholar 

  14. Mottonen T, Hannonen P, Korpela M, et al.; FIN-RACo Trial Group. Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum. 2002;46:894–8.

    Article  CAS  PubMed  Google Scholar 

  15. Nell VP, Machold KP, Eberl G, et al. Benefit of very early referral and very early therapy with disease-modifying, anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford). 2004;43:906–14.

    Article  CAS  Google Scholar 

  16. Puchner R. Job satisfaction and future prospects among Austrian rheumatologists. Z Rheumatol. 2010;69:818–29.

    Article  CAS  PubMed  Google Scholar 

  17. Sanderson T, Morris M, Calnan M, Richards P, Hewlett S. Patient perspective of measuring treatment efficacy: the rheumatoid arthritis patient priorities for pharmacologic interventions outcomes. Arthritis Care Res (Hoboken). 2010;62:647–56.

    Article  CAS  Google Scholar 

  18. Schiava-Winkler U. Österreichischer Patientenbericht Rheumatoide Arthritis 2009. PERI Consulting GmbH Lazarettgasse 19/OH4, 1090 Wien. http://www.patientenbericht.at/files/ergebnisse/Ergebnisse_Rheumatoide_Arthritis.pdf.

  19. Schipper LG, van Hulst LT, Grol R, et al. Meta-analysis of tight control strategies in rheumatoid arthritis: protocolized treatment has additional value with respect to the clinical outcome. Rheumatology. 2010;49:2154–64.

    Article  PubMed  Google Scholar 

  20. Smolen JS, Aletaha D, Bijlsma JW, et al.; T2T Expert Committee. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010;69:631–7.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Smolen JS, Landewe R, Breedveld FC, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis. 2010;69:964–75.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Van der Linden MP, le Cessie S, Raza K, et al. Long-term impact of delay in assessment of patients with early arthritis. Arthritis Rheum. 2010;62:3537–46.

    Google Scholar 

  23. Van Nies JA, De Jong Z, Van der Helm-van Mil AH, et al. Improved treatment strategies reduce the increased mortality risk in early RA patients. Rheumatology. 2010;49:2210–6.

    Article  PubMed  Google Scholar 

  24. Verstappen SM, Bijsma JW, Verklej H, et al. Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys. Arthritis Rheum. 2004;51:488–97.

    Article  CAS  PubMed  Google Scholar 

  25. Verstappen SM, Watson KT, Lunt M, et al. Working status in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology. 2010;49:1570–7.

    Article  PubMed Central  PubMed  Google Scholar 

  26. Westhoff G, Edelmann E, Kekow J, Zink A. Diagnostic spectrum, treatment indication and symptom duration in initial referrals to the rheumatologist. Z Rheumatol. 2010;69:910–8.

    Article  CAS  PubMed  Google Scholar 

  27. Zink A, Huscher D, Schneider M. How closely does rheumatology treatment follow the guidelines? Ambition and reality. Z Rheumatol. 2010;9:318–26.

    Article  Google Scholar 

Download references

Acknowledgements

This project was supported by an unrestricted educational grant from Roche Austria.

Conflicts of interest

The authors declare that there is no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rudolf Puchner MD.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Cite this article

Puchner, R., Brezinschek, H., Herold, M. et al. Quality of care of rural rheumatoid arthritis patients in Austria. Wien Klin Wochenschr 126, 360–367 (2014). https://doi.org/10.1007/s00508-014-0540-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-014-0540-6

Keywords

Schlüsselwörter

Navigation